Evolution of drug consumption in a sample of French workers since 1986: The 'Drugs and Work' study

Pharmacoepidemiology and Drug Safety

Volumn 18, Issue 4, 2009, Pages 335-343

  Boeuf Cazou, O ^a,b   Lapeyre Mestre, M ^a   Niezborala, M ^c   Montastruc, J L ^a,b  

^a UNIVERSITÉ DE TOULOUSE   (France)

^b TOULOUSE UNIVERSITY HOSPITAL   (France)

^c Service Médical Interentreprises de Toulouse   (France)

Author keywords

Cross sectional survey; Drug use patterns; Socio professional category; Workers

Indexed keywords

ANALGESIC AGENT; ANTIINFECTIVE AGENT; ANXIOLYTIC AGENT; GASTROINTESTINAL AGENT; HORMONE; HYPNOTIC SEDATIVE AGENT; INOTROPIC AGENT; PSYCHOTROPIC AGENT; RESPIRATORY TRACT AGENT;

ADULT; AGE DISTRIBUTION; ARTICLE; CROSS-SECTIONAL STUDY; DRUG USE; DRUG UTILIZATION; FEMALE; FRANCE; HEALTH SURVEY; HUMAN; JOB PERFORMANCE; MALE; MEDICAL EXAMINATION; OCCUPATIONAL HEALTH; PHARMACOEPIDEMIOLOGY; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; SEX DIFFERENCE; SOCIAL PROBLEM; TREND STUDY; WORKER; CLINICAL PRACTICE; COMPARATIVE STUDY; HEALTH; HEALTH PROMOTION; MIDDLE AGED; OCCUPATION; PRACTICE GUIDELINE; STATISTICS;

ADULT; CROSS-SECTIONAL STUDIES; DRUG UTILIZATION; DRUG UTILIZATION REVIEW; FEMALE; FRANCE; GUIDELINE ADHERENCE; HEALTH PROMOTION; HUMANS; MALE; MIDDLE AGED; OCCUPATIONS; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; QUESTIONNAIRES; URBAN HEALTH;

EID: 65449190173     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.1713     Document Type: Article

References (47)

1. Legrain M, Lecomte T. La consommation des psychotropes en France et dans quelques pays européens. Ann Pharm Fr 1998; 56: 67-75.
2. Lee D, Bergman U. Studies of drug utilization. In Pharmacoepidemiology 3rd Edition. Strom BL (ed). John Wiley and Sons: Chichester, 2000; 463-481.
3. Montastruc JL. La Pharmacologie Sociale: une nouvelle branche de la Pharmacologie Clinique. Therapie 2002; 57: 420-426.
4. Ngoundo Mbongue TB, Sommet A, Pathak A, et al. 'Medicamentation' of society, non-diseases and non-medications: a point of view from social pharmacology. Eur J Clin Pharmacol 2005; 61: 309-313.
5. Lecadet J, Vidal P, Baris B, et al. Médicaments psychotropes: consommation et pratiques de prescription en France métropolitaine. Données nationales, 2000. Rev Med Ass Maladie 2003; 34: 75-84.
6. La consommation médicamenteuse dans 5 pays européens: une réévaluation. Etude pour le LEEM. Le Pen C, Lemasson H, Roulliere-Ledidec C; Avril 2007. http://www.leem-media.com/leem-image/ leem/document/914.pdf (accessed 17 October 2008).
7. Observatoire national des prescriptions et consommation des médicaments. Etude de la prescription et de la consommation des antibiotiques en ambulatoire. Paris: Agence du médicament. Direction des études et de l'information pharmaco-épidémiologiques; Mai 1998.
8. Observatoire national des prescriptions et consommation des médicaments. Etude de la prescription et de la consommation des antidépresseurs en ambulatoire. Paris: Agence du médicament. Direction des études et de l'information pharmaco-épidémiologiques; Juillet 1998.
9. Goossens H, Ferech M, Vander Stichele R, et al. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 2005; 365: 579-587.
10. Arrêté du 29 mars 2002 portant création du comité national de suivi du plan pour préserver l'efficacité des antibiotiques: Journal Officiel de la République Française no 2002; 90: 17 April.
11. Debrand T, Lengagne P. Working conditions and health of European older workers. Document de travail IRDES 2008; 8.
12. Green F. It's been a hard day's night: the concentration and intensification of work in late twentieth-century Britain. Br J Ind Relat 2001; 39: 53-80.
13. Stavroula L, Griffiths A, Cox T. Work organization and stress: systematic problem approaches for employers, managers and trade union representatives. World Health Organization: Geneva, 2003.
14. Lapeyre-Mestre M, Sulem P, Niezborala M, et al. Conduite dopante en milieu professionnel: étude auprès d'un échantillon de 2106 travailleurs de la région toulousaine. Thérapie 2004; 59: 615-623.
15. Moisan J, Bourbonnais R, Brisson C, et al. Job strain and psychotropic drug use among white-collar workers. Work and Stress 1999; 13: 289-298.
16. Pelfrene E, Vlerick P, Moreau M, et al. Use of benzodiazepine drugs and perceived job stress in a cohort of working men and women in Belgium. Results from the BELSTRESS-study. Soc Sci Med 2004; 59: 433-442.
17. Haslam C, Atkinson S, Brown S, et al. Perceptions of the impact of depression and anxiety and the medication for these conditions on safety in the workplace. Occup Environ Med 2005; 62: 538-545.
18. Kivimaki M, Honkonen T, Wahlbeck K, et al. Organisational down-sizing and increased use of psychotropic drugs among employees who remain in employment. J Epidemiol Community Health 2007; 61: 154-158.
19. Niedhammer I, Lert F, Marne MJ. Psychotropic drug use and shift work among French nurses. 1980-1990. Psychol Med 1995; 25: 329-338.
20. Bancarel Y, Blanc MP, Charrin G, et al. Study of drug consumption in a working environment in France. Fundam Clin Pharmacol 1988; 2: 37-46.
21. Lapeyre-Mestre M, Chastan E, Louis A, et al. Drug consumption in workers in France: a comparative study at a 10-year interval (1996 versus 1986). J Clin Epidemiol 1999; 52: 471-478.
22. Décision du 20 janvier 2003 relatives à la mise en œuvre d'une nouvelle version de la nomenclature des professions et catégories socioprofessionnelles. Journal Officiel de la République Française no 2003; 43: 20 Février.
23. Lemorton C. Rapport d'Information sur la prescription, la consommation et la fiscalité des médicaments. 2008; Paris: Assemblée Nationale; 30 April.
24. Rapport annuel du Haut Conseil pour l'Avenir de l'Assurance Maladie. Paris: Haut Conseil pour l'Avenir de l'Assurance Maladie; Juillet 2006.
25. Kaufman DW, Kelly JP, Rosenberg L, et al. Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey. Jama 2002; 287: 337-344.
26. Ngoundo-Mbongue TB, Niezborala M, Sulem P, et al. Psychoactive drug consumption: performance-enhancing behaviour and pharmacodependence in workers. Pharmacoepidemiol Drug Saf 2005; 14: 81-89.
27. Eggen AE. Pattern of drug use in a general population - prevalence and predicting factors: the Tromso study. Int J Epidemiol 1994; 23: 1262-1272.
28. Del Rio MC, Prada C, Alvarez FJ. The use of medication by the Spanish population. Pharmacoepidemiol Drug Saf 1997; 6: 41-48.
29. Office parlementaire d'évaluation des politiques de santé. Rapport sur le bon usage des médicaments psychotropes. Paris: Assemblée Nationale; Juin 2006.
30. Roquelaure Y, Mariel J, Dano C, et al. Surveillance program of neck and upper limb musculoskeletal disorders: assessment over a 4 year period in a large company. Ann Occup Hyg 2004; 48: 635-642.
31. Gillen M, Yen IH, Trupin L, et al. The association of socioeconomic status and psychosocial and physical workplace factors with musculoskeletal injury in hospital workers. Am J Ind Med 2007; 50: 245-260.
32. Saastamoinen P, Leino-Arjas P, Laaksonen M, et al. Socio-economic differences in the prevalence of acute, chronic and disabling chronic pain among ageing employees. Pain 2005; 114: 364-371.
33. Grandfil N, Sermet C, Auvray L. La prescription d'antibiotiques chez les généralistes: Evolution. 1992-2002. Bulletin d'information en économie de la santé. 2004; 87: 1-8.
34. Guillemot D, Maugendre P, Chauvin C, et al. Consommation des antibiotiques en France. Bulletin Epidémiologie Hebdomadaire. 2004; 32-33: 144-147.
35. Lagnaoui R, Depont F, Fourrier A, et al. Patterns and correlates of benzodiazepine use in the French general population. Eur J Clin Pharmacol 2004; 60: 523-529.
36. Olie JP, Elomari F, Spadone C, et al. Résultats d'une enquête sur l'usage des antidépresseurs en population générale. Encephale 2002; 28: 411-417.
37. Durand E. Médicaments psychotropes et travail: Médicaments antidépresseurs. Documents pour le médecin du travail 2007; 112: 487-508.
38. Mas X, Laporte JR, Frati ME, et al. Drug prescribing and use among elderly people in Spain. Drug Intell Clin Pharm 1983; 17: 378-382.
39. Grijalva CG, Chung CP, Stein CM, et al. Changing patterns of medication use in patients with rheumatoid arthritis in a medicaid population. Rheumatology 2008; 47: 1061-1064.
40. Fialova D, Topinkova E, Gambassi G, et al. Potentially inappropriate medication use among elderly home care patients in Europe. Jama 2005; 293: 1348-1358.
41. Goulding MR. Inappropriate medication prescribing for elderly ambulatory care patients. Arch Intern Med 2004; 164: 305-312.
42. Millar WJ. Multiple medication use among seniors. Health Rep 1998; 9: 11-17.
43. Trifiro G, Barbui C, Spina E, et al. Antidepressant drugs: prevalence, incidence and indication of use in general practice of Southern Italy during the years. 2003-2004. Pharmacoepidemiol Drug Saf 2007; 16: 552-559.
44. Deprez PH, Chinaud F, Clech S, et al. La population traitée par médicaments de la classe des antiasthmatiques en France métropolitaine: données du régime général de l'assurance maladie,2000. Revue Médicale de l'Assurance Maladie 2004; 35: 3-11.
45. Karsenty D, Bourdel H, Cherrier C, et al. La population traitée par médicaments antiépileptiques en France métropolitaine en 2000: les données du régime général de l'Assurance Maladie. Revue Médicale de l'Assurance Maladie 2005; 36: 123-132.
46. Dewa CS, Hoch JS, Lin E, et al. Pattern of antidepressant use and duration of depression-related absence from work. Br J Psychiatry 2003; 183: 507-513.
47. Marliat I, Muratet C, Lapeyre-Mestre M, et al. Sleep, shiftwork, and drug use: results of a case-control study in a working environment. Archives des maladies professionnelles et de médecine du travail 1997; 58: 506-511.